Due to its built-up chemoresistance after prolonged usage, the demand for replacing
platinum in metal-based drugs (MBD) is rising. The first MBD approved by the FDA for …

Alzheimer's disease (AD) is a neurodegenerative disorder primarily characterized by β-
amyloid plaque, intraneuronal tangles, significant neuronal loss and cognitive deficit …

Introduction Alzheimer's disease is a multifactorial neurodegenerative disorder
characterized by beta-amyloid accumulation and tau protein hyperphosphorylation. The …

Alzheimer's disease (AD) remains one of the most formidable neurological disorders,
affecting millions globally. This review provides a holistic overview of the therapeutic …

It is undeniable that as people get older, they become progressively more susceptible to
neurodegenerative illnesses such as Alzheimer's disease (AD). Memory loss is a prominent …

Alzheimer's disease (AD) is a chronic neurological condition that has become a leading
cause of cognitive decline in elder individuals. Hardly any effective medication has been …

The accumulation of amyloid plaques and increased brain redox burdens are
neuropathological hallmarks of Alzheimer's disease. Altered metabolism of essential …

Herein, the structural and photophysical features of two N-based polydentate ligands and
the corresponding Zn (II) complexes are investigated. The obtained compounds were …

In recent years, there has been increasing attention focused on various products belonging
to the imidazopyridine family; this class of heterocyclic compounds shows unique chemical …

Neurological disorders (NDs) have a negative impact on the lives of individuals. There could
be two explanations for this: unclear aetiology and lack of effective therapy. However …